FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999971519> ?p ?o ?g. }

• W1999971519 endingPage "32" @default.
• W1999971519 startingPage "11" @default.
• W1999971519 abstract "Abstract Beta-amyloid precursor protein (APP) is a membrane-spanning protein with a large extracellular domain and a much smaller intracellular domain. APP plays a central role in Alzheimer’s disease (AD) pathogenesis: APP processing generates β-amyloid (Aβ) peptides, which are deposited as amyloid plaques in the brains of AD individuals; point mutations and duplications of APP are causal for a subset of early-onset familial AD (FAD) (onset age <65 years old). However, these mutations in FAD represent a very small percentage of cases (∼1%). Approximately 99% of AD cases are nonfamilial and late-onset, i.e., sporadic AD (SAD) (onset age >65 years old), and the pathophysiology of this disorder is not yet fully understood. APP is an extremely complex molecule that may be functionally important in its full-length configuration, as well as the source of numerous fragments with varying effects on neural function, yet the normal function of APP remains largely unknown. This article provides an overview of our current understanding of APP, including its structure, expression patterns, proteolytic processing and putative functions. Importantly, and for the first time, my recent data concerning its epigenetic regulation, especially in alternative APP pre-mRNA splicing and in the control of genomic rearrangements of the APP gene, are also reported. These findings may provide new directions for investigating the role of APP in neuropathology associated with a deficiency in the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt) found in patients with Lesch-Nyhan syndrome (LNS) and its attenuated variants (LNVs). Also, these findings may be of significance for research in neurodevelopmental and neurodegenerative disorders in which the APP gene is involved in the pathogenesis of diseases such as autism, fragile X syndrome (FXS) and AD, with its diversity and complexity, SAD in particular. Accurate quantification of various APP-mRNA isoforms in brain tissues is needed, and antisense drugs are potential treatments." @default.
• W1999971519 created "2016-06-24" @default.
• W1999971519 creator A5014373072 @default.
• W1999971519 date "2015-03-01" @default.
• W1999971519 modified "2023-10-18" @default.
• W1999971519 title "The human β-amyloid precursor protein: biomolecular and epigenetic aspects" @default.
• W1999971519 cites W120263029 @default.
• W1999971519 cites W1537172952 @default.
• W1999971519 cites W1574440816 @default.
• W1999971519 cites W1587773919 @default.
• W1999971519 cites W1592880910 @default.
• W1999971519 cites W1783111952 @default.
• W1999971519 cites W1925587982 @default.
• W1999971519 cites W1968860622 @default.
• W1999971519 cites W1991841948 @default.
• W1999971519 cites W1992660677 @default.
• W1999971519 cites W1996261165 @default.
• W1999971519 cites W1997647094 @default.
• W1999971519 cites W1998137132 @default.
• W1999971519 cites W2000223104 @default.
• W1999971519 cites W2011258376 @default.
• W1999971519 cites W2012084642 @default.
• W1999971519 cites W2012342473 @default.
• W1999971519 cites W2012862746 @default.
• W1999971519 cites W2029969297 @default.
• W1999971519 cites W2030892371 @default.
• W1999971519 cites W2035636173 @default.
• W1999971519 cites W2041464039 @default.
• W1999971519 cites W2042211936 @default.
• W1999971519 cites W2046847750 @default.
• W1999971519 cites W2048111211 @default.
• W1999971519 cites W2050527189 @default.
• W1999971519 cites W2056790763 @default.
• W1999971519 cites W2063899343 @default.
• W1999971519 cites W2066958493 @default.
• W1999971519 cites W2067445072 @default.
• W1999971519 cites W2068326588 @default.
• W1999971519 cites W2075141112 @default.
• W1999971519 cites W2079400095 @default.
• W1999971519 cites W2086048645 @default.
• W1999971519 cites W2088881960 @default.
• W1999971519 cites W2095519862 @default.
• W1999971519 cites W2097750046 @default.
• W1999971519 cites W2100100832 @default.
• W1999971519 cites W2129267808 @default.
• W1999971519 cites W2130886644 @default.
• W1999971519 cites W2136697740 @default.
• W1999971519 cites W2137449861 @default.
• W1999971519 cites W2146498543 @default.
• W1999971519 cites W2146824244 @default.
• W1999971519 cites W2148351021 @default.
• W1999971519 cites W2156736131 @default.
• W1999971519 cites W2166797651 @default.
• W1999971519 cites W2168713159 @default.
• W1999971519 cites W2169240711 @default.
• W1999971519 cites W2171677841 @default.
• W1999971519 cites W4255625940 @default.
• W1999971519 cites W4323238289 @default.
• W1999971519 doi "https://doi.org/10.1515/bmc-2014-0041" @default.
• W1999971519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25719338" @default.
• W1999971519 hasPublicationYear "2015" @default.
• W1999971519 type Work @default.
• W1999971519 sameAs 1999971519 @default.
• W1999971519 citedByCount "26" @default.
• W1999971519 countsByYear W19999715192016 @default.
• W1999971519 countsByYear W19999715192017 @default.
• W1999971519 countsByYear W19999715192018 @default.
• W1999971519 countsByYear W19999715192019 @default.
• W1999971519 countsByYear W19999715192020 @default.
• W1999971519 countsByYear W19999715192021 @default.
• W1999971519 countsByYear W19999715192022 @default.
• W1999971519 countsByYear W19999715192023 @default.
• W1999971519 crossrefType "journal-article" @default.
• W1999971519 hasAuthorship W1999971519A5014373072 @default.
• W1999971519 hasBestOaLocation W19999715191 @default.
• W1999971519 hasConcept C104317684 @default.
• W1999971519 hasConcept C126322002 @default.
• W1999971519 hasConcept C143065580 @default.
• W1999971519 hasConcept C2779134260 @default.
• W1999971519 hasConcept C31705614 @default.
• W1999971519 hasConcept C41091548 @default.
• W1999971519 hasConcept C502032728 @default.
• W1999971519 hasConcept C54355233 @default.
• W1999971519 hasConcept C71924100 @default.
• W1999971519 hasConcept C78179603 @default.
• W1999971519 hasConcept C86803240 @default.
• W1999971519 hasConceptScore W1999971519C104317684 @default.
• W1999971519 hasConceptScore W1999971519C126322002 @default.
• W1999971519 hasConceptScore W1999971519C143065580 @default.
• W1999971519 hasConceptScore W1999971519C2779134260 @default.
• W1999971519 hasConceptScore W1999971519C31705614 @default.
• W1999971519 hasConceptScore W1999971519C41091548 @default.
• W1999971519 hasConceptScore W1999971519C502032728 @default.
• W1999971519 hasConceptScore W1999971519C54355233 @default.
• W1999971519 hasConceptScore W1999971519C71924100 @default.
• W1999971519 hasConceptScore W1999971519C78179603 @default.
• W1999971519 hasConceptScore W1999971519C86803240 @default.
• W1999971519 hasIssue "1" @default.

• next